Allison Winter

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and activity of anti‐CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol”.

Safety and activity of anti‐CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol

Muscle & Nerve(2022)10.1002/mus.27775

N/A

0.464DataRank · unranked

21 citations

Grace Addy, Margot Rohrer, Caroline Cohen, Aimee Roderick, Allison Winter +29 more

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3815

N/A

0DataRank · unranked

116 citations

Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle M. Brander +49 more

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Blood(2023)10.1182/blood-2023-173992

N/A

0DataRank · unranked

0 citations

Ted Gooley, Tanya Siddiqi, Deborah M. Stephens, Catherine M. Broome, Stephen E. Spurgeon +18 more

Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment

Ophthalmology Retina(2025)10.1016/j.oret.2025.09.002

N/A

0DataRank · unranked

4 citations

Adrienne Delaney, Matthew Schulgit, Gabriel Castilho Sandoval Barbosa, Andrea Arline, Yuka Mizuno +12 more

143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)

Hematological Oncology(2025)10.1002/hon.70093_143

N/A

0DataRank · unranked

1 citations

Constance Lau, Mazyar Shadman, Alex F. Herrera, Caron A. Jacobson, F. L. Locke +13 more

Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory (R/R) secondary central nervous system lymphoma (SCNSL).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7024

N/A

0DataRank · unranked

0 citations

Babatunde Adedokun, Hamza Hashmi, Mazyar Shadman, Allison Winter, Alex F. Herrera +14 more